leflunomide and pyrazines

leflunomide has been researched along with pyrazines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chaudhry, V; Umapathi, T	1
Bogachkov, Y; Doscas, ME; Kaufman, H; Li, Y; Rao, GS; Ruby, C; Usha, L; Wang, Y; Williams, JW; Williamson, AJ; Xiao, F; Xu, X; Zhou, J	1
Bajzikova, M; Boukalova, S; Coelho, A; Davidova, E; Ditzel, HJ; Hubackova, S; Kovarova, J; Neuzil, J; Rohlena, J; Terp, MG	1

Reviews

1 review(s) available for leflunomide and pyrazines

Article	Year
Toxic neuropathy. Current opinion in neurology, 2005, Volume: 18, Issue:5 Topics: Animals; Boronic Acids; Bortezomib; Clinical Trials as Topic; Epothilones; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoxazoles; Leflunomide; Neuritis; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyrazines; Pyridoxine; Thalidomide	2005

Article

Year

Toxic neuropathy.

Current opinion in neurology, 2005, Volume: 18, Issue:5

Topics: Animals; Boronic Acids; Bortezomib; Clinical Trials as Topic; Epothilones; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoxazoles; Leflunomide; Neuritis; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyrazines; Pyridoxine; Thalidomide

2005

Other Studies

2 other study(ies) available for leflunomide and pyrazines

Article	Year
Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress. Neoplasia (New York, N.Y.), 2014, Volume: 16, Issue:10 Topics: Aniline Compounds; Butadienes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Crotonates; Feedback, Physiological; Gene Knockdown Techniques; Humans; Hydroxybutyrates; Imidazoles; Isoxazoles; Leflunomide; MAP Kinase Signaling System; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Pyrazines; Receptor, IGF Type 1; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines	2014
Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors. Cell death & disease, 2020, 02-07, Volume: 11, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 1; Dihydroorotate Dehydrogenase; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; HCT116 Cells; Humans; Leflunomide; MCF-7 Cells; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Oxidoreductases Acting on CH-CH Group Donors; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Ribosomes; Signal Transduction; Tumor Suppressor Protein p53	2020

Article

Year

Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.

Neoplasia (New York, N.Y.), 2014, Volume: 16, Issue:10

Topics: Aniline Compounds; Butadienes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Crotonates; Feedback, Physiological; Gene Knockdown Techniques; Humans; Hydroxybutyrates; Imidazoles; Isoxazoles; Leflunomide; MAP Kinase Signaling System; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Pyrazines; Receptor, IGF Type 1; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines

2014

Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors.

Cell death & disease, 2020, 02-07, Volume: 11, Issue:2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 1; Dihydroorotate Dehydrogenase; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; HCT116 Cells; Humans; Leflunomide; MCF-7 Cells; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Oxidoreductases Acting on CH-CH Group Donors; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Ribosomes; Signal Transduction; Tumor Suppressor Protein p53

2020